New microGRID technology for timsTOF fleX platform for MALDI positioning provides virtually artifact-free images across entire slide down to 5 µm MINNEAPOLIS--(BUSINESS WIRE)--At the 70th ASMS ...

The timsTOF fleX integrates best-in-class 4D X-Omics with Bruker’s revolutionary MALDI Imaging technology, including SmartBeam 3D laser optics for rapid measurement all-in-one system, based on the ...

Advances in cell biology, neurology, oncology, and other disease-based research require an understanding of the spatial dynamics and interplay between heterogeneous cellular populations. Understanding ...

Bruker Corporation BRKR recently announced the launch of the neofleX Imaging Profiler for mass spectrometry-based tissue imaging at the 72nd ASMS meeting. The novel, high-performance MALDI-TOF/TOF ...

Single-cell MALDI mass spectrometry (MS) imaging resolution is currently limited by the size of laser spot diameter, matrix crystal size/homogeneity, displacement of analytes during matrix deposition, ...

The new MALDI Tissuetyper based on the rapifleX instrument re-defines the key performance measures for MALDI imaging and allows for completely new projects and measurement strategies. The rapifleX ...

WATERTOWN, Mass.--(BUSINESS WIRE)--Boston-area life science technology company AmberGen Inc. today announced that it has closed a strategic investment by Bruker Corporation, one of the world's leading ...

The interdisciplinary field of spatial biology continues to connect omics research with the goal of understanding the spatial distribution of biomolecules that influence biological processes and ...

MINNEAPOLIS--(BUSINESS WIRE)-- At the 70th ASMS Conference, Bruker Corporation (Nasdaq: BRKR) announced key innovations for spatial multiomics of tissue and tumor microenvironments (TME). Following ...